Nevertheless, mTOR inhibitors have shown limited efficacy in unselected clinical trials for adult IBD patients [27], although rapamycin has shown clinical efficacy in individual adult cases and in a study of pediatric IBD patients [28,29]. The gene discussed is MTOR; the disease is inflammatory bowel disease.